Global High-Priority Regulatory Events — July 17, 2026

Global High Priority Market Events

By Gunpowder Editorial ·

50 high priority 50 total filings analysed

Executive Summary

The July 17, 2026, filing set reveals a market dominated by corporate restructuring, insolvency proceedings, and strategic M&A, with a notable concentration of distress in Indian real estate and financial services.

Key period-over-period trends include significant revenue declines from asset sales (Braemar Hotels: -18% pro forma revenue drop) and margin compression from regulatory penalties (Jana Small Finance Bank: 22.5% NPA divergence). The most critical developments are the appointment of a receiver for Fuse Science (insolvent, $0 assets), Nasdaq delisting threats for Actuate Therapeutics and Dare Bioscience, and a transformative 99% capital reduction at Oxford Industries following a change in control. Portfolio-level patterns show a surge in SPAC activity (4 IPOs/amendments) and a wave of Indian insolvency updates (7 filings), signaling a bifurcated market where capital is flowing to new blank-check vehicles while legacy entities face liquidation or restructuring. The overall sentiment is cautiously negative, with 18 filings carrying negative or mixed sentiment, but pockets of opportunity exist in renewable energy (DCM Shriram) and aerospace (NRB Bearing).

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from July 16, 2026.

Investment Signals (10)

  • Acquisition of Mahant Tool Room completed, securing AS9100D aerospace certification, targeting a $14.5B-$16.5B market. The company aims to double consolidated revenue by 2031, a 100% growth target over 5 years

  • Acquired 26% stake in a renewable SPV for ₹105 Cr, securing 58 MW of power for its Bharuch plant. The project is expected to avoid 0.4M tonnes of CO2 annually, with commissioning by June 2027, enhancing long-term cost savings

  • Acquired Kira Pharmaceuticals in an all-stock deal with a $132M PIPE, funding operations through 2H 2028. The combined pipeline includes KP-104 and briquilimab, with key milestones expected through 2028

  • New promoter Saroj Kumar Choudhary (46.46% stake) approved a 99% capital reduction to offset accumulated losses, signaling a clean-slate restructuring. The shift to healthcare/pharma objects opens new growth avenues

  • Sold three properties for $432.7M, repaying $232.8M in debt. Pro forma net income improved from a -$72.7M loss to +$96.7M, though ongoing hotel revenue declined 18% to $575.5M, indicating a leaner but more profitable core

  • Receiver appointed after failing to satisfy a $643,471 judgment. The company reported $0 in assets and $0 cash, is insolvent, and has relocated assets abroad—a total loss for equity holders

  • Received Nasdaq delisting notice for MVLS below $50M. The company has 180 days to regain compliance, but failure could lead to delisting, severely impacting liquidity

  • Received Nasdaq delisting notice for stockholders' equity below $2.5M. The company plans to appeal, but the risk of delisting is high, with no assurance of success

  • RBI inspection revealed a ₹169 Cr divergence in GNPA (22.5% above reported), requiring ₹42 Cr additional provisioning. The bank's asset quality is worse than disclosed, signaling regulatory risk

  • Mandatory open offer at ₹56.84/share for 25.05% of shares, with the Dholu family set to hold 99.63% post-offer. The IDC deemed the price fair, but minority shareholders face near-total delisting risk

Risk Flags (10)

  • Receiver appointed with full authority to wind down the business. The company has $0 assets, $0 cash, and is permanently enjoined from transferring assets or issuing shares. Equity is worthless

  • Nasdaq notice for MVLS below $50M. The company has 180 days to comply, but if it fails, the stock will be delisted, causing a liquidity crisis

  • Nasdaq notice for stockholders' equity below $2.5M. The company's continued listing is uncertain, and a hearing request may not succeed

  • RBI found a ₹169 Cr GNPA divergence (22.5% of reported). The bank's asset quality is materially worse than disclosed, and additional provisioning of ₹42 Cr has already been required

  • Pro forma hotel revenue dropped 18% from $704M to $575.5M after asset sales. The company's earnings power has been significantly reduced, and the gain on sale is non-recurring

  • The 11th CoC meeting approved a 60-day CIRP extension, and the Resolution Professional's AFA expired on June 30, 2026, raising compliance concerns. The process is stalling

  • The 12th CoC meeting was rescheduled from July 2 to July 14, 2026, with no resolution outcome disclosed. The CIRP, initiated in September 2025, is dragging on without progress

  • Received a Form 3 demand notice for ₹4.31 Cr in unpaid operational debt from a coal supplier. While the company expects to resolve amicably, the notice signals potential insolvency proceedings

  • Satya MicroCapital/Regulatory Penalty [LOW RISK]

    RBI imposed a ₹3.10 lakh penalty for failing to classify certain accounts as NPAs upon restructuring. The penalty indicates systemic compliance failures in asset classification

  • Dhani Loans and Services/Regulatory Penalty [LOW RISK]

    RBI imposed a ₹2.70 lakh penalty for non-compliance with asset classification directions. The penalty, though small, signals regulatory scrutiny of NPA recognition practices

Opportunities (10)

  • The acquisition of Mahant Tool Room and AS9100D certification positions NRB to enter the $14.5B-$16.5B global aerospace and defence market. The company aims to double revenue by 2031, offering a 100% growth catalyst over 5 years

  • The ₹105 Cr investment in a 58 MW hybrid renewable project (solar + wind) will provide 36 MW round-the-clock power, reducing energy costs and CO2 emissions by 0.4M tonnes annually. Commissioning by June 2027 offers a clear catalyst

  • The acquisition of Kira Pharmaceuticals and $132M PIPE funds operations through 2H 2028. The combined pipeline includes KP-104 (bifunctional complement inhibitor) and briquilimab (anti-KIT), with key milestones expected through 2028. The CVR payments of up to $30M are contingent on a priority review voucher by end of 2028

  • New promoter with 46.46% stake approved a 99% capital reduction to offset accumulated losses, shifting to healthcare/pharma. The clean-slate restructuring and new business objects offer a potential turnaround story, though execution risk is high

  • Acquiring an 81% stake in YGCL (listed on Tokyo Stock Exchange) and 11% in Shinnichi Kogyo. The acquisition is expected to close in Q2 FY2026-27, expanding Motherson's global automotive footprint

  • Completed acquisition of 51-55% stake in Occlutech Holding AG, a Swiss company, making it a step-down subsidiary. The deal expands Alkem's presence in the medical devices space, though no financial terms were disclosed

  • NCLT sanctioned the demerger of its Bio Pharma Undertaking into Ennature Bio Pharma and its Spirits and Biofuel Undertaking into IGL Spirits. The demerger unlocks value by creating two focused entities, with the order pronounced on July 17, 2026

  • Filed NCLT application for the Scheme of Amalgamation with Profectus Capital. The merger, approved by the board on January 8, 2026, and receiving exchange observation letters on July 10, 2026, could create a stronger NBFC with combined scale

  • Received NCLT approval for its Resolution Plan to acquire Creatoz Builders Private Limited (CBPL) under IBC. The acquisition allows Authum to enter the real estate sector and monetize underlying assets, with the NCLT order uploaded on July 16, 2026

  • Completed a $275M IPO, focusing on mining and critical minerals. As a blank-check company with no operations, it offers a pure-play vehicle for exposure to the critical minerals sector, though target identification risk is high

Sector Themes (6)

  • Insolvency Wave in Indian Real Estate and Financials

    7 filings relate to Indian insolvency proceedings (Ansal Buildwell, Reliance Home Finance, BIL Vyapar, Keerthi Industries, Unitech International, Bloom Dekor, VeeFin Solutions). The common theme is stalled CIRP processes, with multiple CoC meetings and extension requests, indicating a systemic logjam in India's IBC resolution framework. Investors should monitor for potential liquidation risks.

  • SPAC Activity Surge with Sector Focus

    4 SPAC-related filings (Freedom Metals, Mercator Acquisition, Tribeca Strategic, Inflection Point) show a renewed appetite for blank-check vehicles, with a focus on mining/critical minerals, technology/software, and AI. The $275M Freedom Metals IPO and $150M Mercator IPO suggest institutional demand for thematic SPACs, though target identification risk remains high.

  • Regulatory Scrutiny on Asset Classification in Indian NBFCs

    3 filings (Satya MicroCapital, Dhani Loans and Services, Jana Small Finance Bank) involve RBI penalties or divergence in NPA classification. The common thread is that NBFCs are under-reporting NPAs, with Jana's divergence of 22.5% being particularly severe. This signals heightened regulatory risk for the sector, with potential for further penalties or provisioning requirements.

  • Corporate Restructuring via Demergers and Capital Reduction

    3 filings (India Glycols, Oxford Industries, VeeFin Solutions) involve demergers or capital reduction schemes. India Glycols' demerger of two undertakings into separate entities, Oxford Industries' 99% capital reduction, and VeeFin's amalgamation scheme all point to a trend of corporate simplification and value unlocking. Investors should watch for similar actions in other conglomerates.

  • Nasdaq Delisting Threats for Small-Cap Biotechs

    2 filings (Actuate Therapeutics, Dare Bioscience) involve Nasdaq delisting notices for failure to meet minimum listing standards. Both companies are small-cap biotechs with limited cash and no approved products. The delisting risk is a sector-wide concern for micro-cap biotechs, potentially leading to liquidity crises and forced financing at distressed valuations.

  • M&A in Indian Manufacturing with Aerospace and Renewable Focus

    3 filings (NRB Bearing, DCM Shriram, Samvardhana Motherson) involve strategic acquisitions in high-growth sectors. NRB's entry into aerospace, DCM Shriram's renewable energy investment, and Motherson's acquisition of a Japanese auto parts maker all signal a shift towards value-added manufacturing and sustainability. These deals offer long-term growth catalysts.

Watch List (8)

  • The tender offer has been extended to July 20, 2026, with 64.67% of shares tendered. The merger agreement's outside date is July 21, 2026. Watch for the final outcome and potential price movement if the deal closes or fails.

  • The company has 180 days (until January 11, 2027) to regain MVLS compliance. Watch for any reverse stock split or financing announcement that could boost the stock price above $50M.

  • The company intends to request a hearing before a Nasdaq Hearing Panel. Watch for the hearing date and the panel's decision, which will determine the company's continued listing.

  • The 99% capital reduction, shift of registered office, and change in business objects are subject to shareholder approval. Watch for the AGM date and voting results, which will determine the success of the restructuring.

  • NDTV/GoodTimes Acquisition
    👁

    The acquisition of the 'GoodTimes' channel business is expected to close within approximately 3 months from July 17, 2026. Watch for regulatory approvals and any further delays.

  • The NCLT application was filed on July 16, 2026. Watch for the NCLT hearing date and approval, which will be a key catalyst for the merged entity.

  • The record date is July 31, 2026, for the reduction and cancellation of shares under the NCLT-approved resolution plan. Watch for the impact on share price and potential delisting.

  • The open offer runs from July 20 to July 31, 2026, at ₹56.84/share. Watch for the final acceptance level, which will determine the post-offer shareholding structure and potential delisting.

Filing Analyses (50)
NRB Bearing Limited Merger/Acquisition positive materiality 8/10

17-07-2026

NRB Bearings Limited announced that its wholly owned subsidiary, Mahant Tool Room Private Limited (MTRPL), completed the acquisition of Mahant Tool Room (MTR), a sole proprietorship, on July 17, 2026. Concurrently, MTRPL obtained the AS9100D aerospace certification, positioning NRB to enter the global aerospace and defence market, which is estimated at $14.5B–$16.5B. The acquisition follows a previously disclosed intimation from January 27, 2026, and the company expects this to accelerate its goal of doubling consolidated revenue by 2031.

  • · NRB Bearings Limited was established in 1965 and is headquartered in Mumbai, India.
  • · NRB serves customers in over 40 countries with subsidiaries in USA, Europe, Thailand, and the UAE.
  • · The acquisition was disclosed to stock exchanges on January 27, 2026, and completed on July 17, 2026.
  • · NRB holds a commanding position in electric and hybrid vehicle platforms and industrial applications.
Shakti Pumps (India) Limited Merger/Acquisition positive materiality 7/10

17-07-2026

Shakti Pumps (India) Limited has invested ₹5,00,00,000 (₹5.00 Crore) in its wholly owned subsidiary Shakti EV Mobility Private Limited by subscribing to 50,00,000 equity shares of ₹10 each. This brings the total consolidated investment in the subsidiary to ₹70,00,00,000 (₹70 Crore). The investment aims to initiate and expand the subsidiary's business in manufacturing electric vehicle motors and chargers.

  • · Shakti EV Mobility was incorporated on December 16, 2021.
  • · The subsidiary's total asset size as of March 31, 2026 was ₹12,857.28 Lacs.
  • · The investment is made in cash by subscribing to equity shares.
  • · No governmental or regulatory approvals are required for the acquisition.
  • · The acquisition was completed on the same day.
Chemcrux Enterprises Limited Merger/Acquisition neutral materiality 3/10

17-07-2026

Chemcrux Enterprises Limited announced the incorporation of its wholly owned subsidiary, Chemcrux Foundation, a Section 8 (non-profit) company, to fulfill its CSR obligations. The subsidiary was incorporated on July 17, 2026, with an authorized and paid-up share capital of ₹1,00,000, acquired for cash consideration of ₹1,00,000 (10,000 equity shares at ₹10 each). The subsidiary is yet to commence business operations and has no turnover.

  • · The subsidiary is a related party due to common directors and promoters, and the transaction is at arm's length.
  • · Chemcrux Foundation is incorporated under the jurisdiction of ROC Ahmedabad (Gujarat).
  • · The subsidiary's objects include promotion of commerce, art, science, sports, education, research, social welfare, healthcare, charity, and environmental protection.
Kuva Labs, Inc. SC TO-T/A neutral materiality 8/10

17-07-2026

Kuva Labs Inc., through its subsidiary Kuva Acquisition Corp., is extending its tender offer to acquire all outstanding shares of Lisata Therapeutics, Inc. The offer price is $4.00 per share in cash plus one contingent value right (CVR) of up to $3.00 per share. As of July 15, 2026, approximately 5,897,848 shares (64.67% of outstanding) had been tendered, and the offer expiration has been extended to July 20, 2026. The merger agreement's outside date has also been extended to July 21, 2026.

  • · The tender offer was originally scheduled to expire on July 16, 2026, but has been extended to July 20, 2026.
  • · The merger agreement's outside date was extended from July 17, 2026 to July 21, 2026.
  • · The offer is a third-party tender offer subject to Rule 14d-1.
  • · The filing is an amendment (No. 2) to the initial Schedule TO filed on June 10, 2026.
Jasper Therapeutics, Inc. 8-K mixed materiality 9/10

17-07-2026

Jasper Therapeutics, Inc. (NASDAQ: JSPR) announced the acquisition of Kira Pharmaceuticals in an all-stock transaction, concurrently raising $132 million in a PIPE offering. On a fully diluted basis, pre-transaction Jasper equityholders will own approximately 6.68%, Kira equityholders will own approximately 49.86%, and PIPE investors will own approximately 43.46% of the combined company. The combined entity plans to advance a pipeline including KP-104 (a bifunctional complement inhibitor targeting C5 and Factor H) and briquilimab (anti-KIT), with key milestones expected through 2028. However, the transaction significantly dilutes existing Jasper shareholders, and the company faces substantial risks related to clinical development, regulatory approval, and the realization of CVR payments contingent on a priority review voucher.

  • · The combined company expects to fund operations through 2H 2028 with the $132M PIPE proceeds.
  • · CVR payments of up to $30M are contingent on Jasper obtaining a priority review voucher for briquilimab by end of 2028.
  • · Out-license of KP-301 and KP-402 to Mirador Therapeutics includes $12M upfront and potential development/sales milestones.
  • · KP-104 has a Phase 2 basket trial with interim data expected Q4 2026 (Stage 1) and Q2 2027 (Stage 2).
  • · Briquilimab has Orphan Drug, Fast Track, and Rare Pediatric Disease Designations in SCID.
  • · The global complement inhibitor market is estimated at $14B+ (2025A-2032E).
Freedom Metals Acquisition Corp. 8-K neutral materiality 8/10

17-07-2026

Freedom Metals Acquisition Corp. completed its initial public offering (IPO) of 27,500,000 units at $10.00 per unit, raising $275,000,000 in gross proceeds, and simultaneously closed a private placement of 825,000 units to the sponsor and underwriters for $8,250,000. The net proceeds were placed in a trust account to fund a future business combination, with the company focusing on targets in the mining and critical minerals industry. As a blank-check company with no operations, it faces risks in identifying and completing a suitable acquisition within the required timeframe.

  • · The company is a blank-check (SPAC) incorporated in the Cayman Islands on February 25, 2026, with no operations and no identified business combination target.
  • · The underwriters forfeited their over-allotment option on July 9, 2026, resulting in the surrender of 1,375,000 Class B ordinary shares by the Sponsor for no consideration.
  • · Transaction costs totaled $17,592,906, including $5,500,000 cash underwriting fees and $11,000,000 deferred underwriting fees.
  • · The company has a shareholders' deficit of $8,981,439, reflecting accumulated deficit of $8,982,439.
  • · The trust account holds $275,000,000, representing $10.00 per public share, which will be used to fund a business combination or returned to shareholders if no deal is completed.
  • · The company intends to focus on targets in the mining and critical minerals industry but may pursue any business.
Activate Energy Acquisition Corp. 8-K neutral materiality 2/10

17-07-2026

Activate Energy Acquisition Corp. (AEAQU) announced the resignation of Director Paul Moore from its Board, effective July 13, 2026. The departure was not related to any disagreement with the company regarding its operations, policies, or practices. The Board thanked Mr. Moore for his service.

  • · The resignation was effective immediately on July 13, 2026.
  • · The company is a blank check (SPAC) incorporated in the Cayman Islands.
  • · Its securities trade on the Nasdaq Global Market under symbols AEAQU (Units), AEAQ (Class A ordinary shares), and AEAQW (Warrants).
Braemar Hotels & Resorts Inc. 8-K mixed materiality 8/10

17-07-2026

Braemar Hotels & Resorts Inc. completed the sale of three hotel properties (The Ritz-Carlton Sarasota, Hotel Yountville, and Bardessono Hotel and Spa) for approximately $432.7 million in cash, net of transfer taxes and selling expenses, and repaid approximately $232.8 million on the related mortgage loan. The pro forma financials show a significant non-recurring gain of $158.2 million for the year ended December 31, 2025, but also reflect the removal of these properties' revenues and operating income, leading to a decline in ongoing hotel revenue from $704.0 million to $575.5 million. While the sale strengthens the balance sheet with increased cash and reduced debt, it also reduces the company's asset base and future operating income from the disposed properties.

  • · The sale closed on July 14, 2026.
  • · The pro forma gain on disposition is preliminary and subject to change.
  • · Pro forma net income attributable to common stockholders for the year ended Dec 31, 2025 improved from a loss of $72.7M to income of $96.7M, primarily due to the non-recurring gain.
  • · Pro forma net income attributable to common stockholders for the three months ended Mar 31, 2026 declined from $4.9M to $1.2M, reflecting the removal of the properties' operating results.
  • · Pro forma total assets decreased by $138.1M (7.5%) from $1.85B to $1.71B.
  • · Pro forma indebtedness decreased by $232.2M (21.0%) from $1.11B to $873.9M.
  • · Pro forma cash and cash equivalents increased by $188.2M (201.5%) from $93.4M to $281.6M.
  • · The disposed properties had combined operating losses (before gain) of $7.6M for the year ended Dec 31, 2025 and $1.9M for the three months ended Mar 31, 2026.
Constellation Acquisition Corp I 8-K neutral materiality 5/10

17-07-2026

Constellation Acquisition Corp I (CSTA) filed an 8-K on July 17, 2026, disclosing that Ian Rodger, CEO of HiTech Minerals Inc. and incoming CEO of US Elemental Inc. (PubCo), participated in a Water Tower Research Fireside Chat on July 16, 2026, discussing the proposed business combination between CSTA, HiTech, and PubCo. The filing includes a transcript of the discussion and forward-looking statements regarding the merger, anticipated Nasdaq listing, and financial projections. No specific financial figures or period-over-period comparisons are provided in this disclosure.

  • · The business combination involves CSTA, HiTech, and PubCo (US Elemental Inc.).
  • · PubCo is expected to list on Nasdaq after the business combination.
  • · The filing includes cautionary notes regarding forward-looking statements and risks.
  • · A Registration Statement on Form S-4 is being prepared for the transaction.
  • · Shareholders are urged to read the proxy statement/prospectus when available.
Mercator Acquisition Corp. 8-K neutral materiality 8/10

17-07-2026

Mercator Acquisition Corp., a blank check company, priced its $150 million initial public offering of 15,000,000 units at $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. The units will trade on Nasdaq under the symbol 'MRCOU' starting July 9, 2026. The company intends to focus on technology and software infrastructure companies targeting financial services, real estate, and asset management, and is led by Shawn Matthews (Chairman & CEO), Steve Bischoff (CFO), and Shawn Matthews Jr. (President).

  • · The company is a blank check company formed to effect a merger or similar business combination.
  • · The offering was declared effective by the SEC on July 8, 2026.
  • · The company has granted underwriters a 45-day option to purchase up to an additional 2,250,000 units to cover over-allotments.
  • · Only whole warrants are exercisable and will trade separately.
Tribeca Strategic Acquisition Corp. 8-K neutral materiality 3/10

17-07-2026

Tribeca Strategic Acquisition Corp. announced that, effective July 20, 2026, holders of its units may elect to separately trade the Class A ordinary shares and rights included in the units. The separated shares and rights will trade on Nasdaq under symbols 'BID' and 'BIDWR', respectively, while units not separated will continue to trade under 'BIDWU'. The company is a blank check SPAC focused on software, technology, AI, digital assets, and clean energy sectors.

  • · Separate trading of Class A ordinary shares and rights begins July 20, 2026.
  • · Transfer agent for unit separation is Efficiency, INC.
  • · Company is an emerging growth company as defined under SEC rules.
  • · SPAC intends to target high-growth sectors including software, technology, artificial intelligence, digital assets, and clean energy.
Ansal Buildwell Ltd. Insolvency mixed materiality 8/10

17-07-2026

Ansal Buildwell Ltd. disclosed that its subsidiary Ansal Crown Infrabuild Pvt. Ltd. (the Corporate Debtor) had a Resolution Plan submitted by M/s Nanu Ram Goyal & Co. (NRG & Co.) approved by the CoC (98.52% vote) and sanctioned by the NCLT New Delhi Bench (order dated 02.07.2026). The Plan’s total value is Rs. 3,21,33,36,000/- and realisable amount under the plan is Rs. 3,193.336.331 (as reported); however, only 45.55% of total admitted claims are proposed to be realised (Realizable amount 31260.00 in Form H table) and certain classes (e.g., some unsecured financial creditors) show NIL realizations in the plan table, indicating mixed recovery prospects for stakeholders.

  • · NCLT order date: 02.07.2026 (Order delivered).
  • · Corporate Insolvency admission date for Ansal Crown Infrabuild Pvt. Ltd.: 21.04.2023 (CIRP commencement).
  • · Resolution Plan (Revised) dated 22.03.2024 was approved by CoC in its 14th meeting on 02.04.2024 by 98.52% vote.
  • · Form-G and multiple EOI rounds: initial Form-G published 17.09.2023 with subsequent Form-G published 01.01.2024; last date for resolution plans listed as 23.02.2024 in schedule.
  • · CoC meetings timeline includes key meetings on 24.05.2023 (1st CoC), 13.06.2023 (22nd referenced), 30.06.2023, 11.08.2023, 06.09.2023, 30.11.2023, 26.12.2023, 23.01.2024, 26.02.2024, 01.03.2024, 09.03.2024, 23.03.2024 and 02.04.2024.
  • · Operational Creditor contingent DTCP claim: Rs. 2107.90 Lacs (Principal Rs. 835.42 Lacs & Interest/Penal Interest Rs. 1272.48 Lacs) — noted as stayed by Court and to be borne by allottees per builder-buyer agreements.
Reliance Home Finance Limited Insolvency negative materiality 8/10

17-07-2026

Reliance Home Finance Limited, currently under Corporate Insolvency Resolution Process (CIRP), held its 12th Committee of Creditors (CoC) meeting on July 14, 2026, via video conferencing. The meeting was originally scheduled for July 2, 2026, but was rescheduled. This is a post-facto intimation to the stock exchanges under SEBI Listing Regulations.

  • · The 12th CoC meeting was originally scheduled for July 2, 2026, but was rescheduled to July 14, 2026.
  • · The meeting was conducted through Video Conferencing.
  • · The CIRP was initiated on September 20, 2025.
  • · The Resolution Professional is Umesh Balaram Sonkar, registered with IBBI.
Four Leaf Acquisition Corp 8-K mixed materiality 8/10

17-07-2026

Four Leaf Acquisition Corp terminated its business combination agreement with Guangzhou Xiaoyu DiDa Technology Co., Ltd. (XYDD) on July 15, 2026, due to a halt in regulatory review under PRC law, in order to pursue a new business combination with Data443 Risk Mitigation, Inc. As compensation for the termination, Data443 issued a $2,000,000 promissory note to XYDD, payable in two installments after deal close, with potential conversion into PubCo shares at a discount. The company is not obligated to pay any termination fee.

  • · The XYDD Business Combination Agreement was originally entered into on December 19, 2024.
  • · The Compensation Agreement between Data443 and XYDD was entered into on June 25, 2026.
  • · Data443 may repay the loan in full at any time before 12 months after deal close.
  • · Any portion of the loan that cannot be converted due to the floor or cap remains payable in cash on demand.
  • · Disputes under the Compensation Agreement are to be resolved by arbitration administered by the Singapore International Arbitration Centre.
BIL VYAPAR LIMITED Insolvency negative materiality 8/10

17-07-2026

BIL Vyapar Limited (formerly Binani Industries Limited), currently under Corporate Insolvency Resolution Process (CIRP), has informed stock exchanges that the 17th meeting of the Committee of Creditors (CoC) will be held on July 17, 2026. The disclosure is made under Regulation 30 of SEBI LODR. No financial details or outcomes of the meeting are provided.

  • · The company is under CIRP (Corporate Insolvency Resolution Process).
  • · This is the 17th meeting of the Committee of Creditors.
  • · The meeting is scheduled for July 17, 2026.
Keerthi Industries Ltd Insolvency negative materiality 8/10

17-07-2026

Keerthi Industries Ltd has received a demand notice (Form 3) under the Insolvency and Bankruptcy Code, 2016 from J P Associates, a regular coal supplier, for an unpaid operational debt of ₹4,31,09,759 (principal ₹3,33,91,437 plus interest ₹97,18,322). The company is reviewing the notice with legal counsel and expects to resolve the matter amicably, stating no material impact on operations or financial position.

  • · Demand notice (Form 3) received on July 16, 2026
  • · Debt is operational in nature, related to coal supply
  • · Company states no financial impact on operations or other activities
  • · Company expects to settle amicably within statutory timelines
LISATA THERAPEUTICS, INC. SC 14D9/A neutral materiality 8/10

17-07-2026

Lisata Therapeutics filed an amendment to its Schedule 14D-9, disclosing that the tender offer by Kuva Acquisition Corp. has been extended to July 20, 2026. As of July 15, 2026, approximately 5,897,848 shares (64.67% of outstanding) had been validly tendered, indicating strong but not yet full shareholder participation. The offer price is $4.00 per share plus up to $3.00 per share in contingent value rights (CVRs), and the merger agreement's outside date has been extended to July 21, 2026.

  • · The tender offer expiration was extended from July 16, 2026 to July 20, 2026.
  • · The merger agreement's outside date was extended from July 17, 2026 to July 21, 2026.
  • · The depositary reported 5,897,848 shares tendered as of 5:30 p.m. on July 15, 2026.
  • · The offer price consists of $4.00 per share at closing plus up to $3.00 per share in contingent value rights (CVRs).
Euro Panel Products Limited Merger/Acquisition neutral materiality 4/10

17-07-2026

Euro Panel Products Limited has incorporated a new subsidiary, Eurobond Dimensions Private Limited, effective July 15, 2026, subscribing to 70% of its share capital for cash at face value. The subsidiary is in the same line of business (aluminium composite panels and allied metal products) and is expected to create operational synergies. However, as a newly incorporated entity, it has no turnover yet, and the near-term financial impact is minimal.

  • · The subsidiary was incorporated in Maharashtra, India.
  • · Two directors of the parent company, Rajesh Nanalal Shah and Divyam Rajesh Shah, have been appointed as directors of the subsidiary.
  • · The acquisition does not fall within related party transactions, except for the director appointments.
  • · No governmental or regulatory approvals were required for the incorporation.
  • · The consideration is cash, paid at face value of the equity shares.
INDONG TEA COMPANY LIMITED Fraud Investigation neutral materiality 4/10

17-07-2026

Indong Tea Company disclosed the closure of a GST investigation by the Deputy Commissioner of State Tax, West Bengal, initiated in November 2025. Key issues (exempted goods documentation and booking of supply of farm labour) were reconciled during hearings, resulting in no tax liability or material financial impact. However, the filing reveals procedural lapses—the company initially failed to produce transport documents during the inspection.

  • · Investigation was initiated under section 67(1) of the West Bengal GST Act, 2017 on 21-11-2025 at the company's registered office.
  • · Personal hearings were held on 13/01/2026, 05/02/2026, 07/02/2026, and 26/02/2026.
  • · The company entered a 'Plantation Development Works Agreement' with Vista Solar Energy Limited on 14/02/2023 for tea estate development.
  • · No material impact on financials, operations, or other activities of the company was reported.
Unknown Default negative materiality 5/10

17-07-2026

The Reserve Bank of India (RBI) imposed a monetary penalty of ₹3.10 lakh on Satya MicroCapital Limited for non-compliance with asset classification directions, specifically failing to classify certain accounts as non-performing assets upon restructuring. The penalty, dated July 13, 2026, follows a statutory inspection as of March 31, 2025, and is based on sustained deficiencies in regulatory compliance.

  • · The penalty was imposed under Section 58G(1)(b) read with Section 58B(5)(aa) of the Reserve Bank of India Act, 1934.
  • · The statutory inspection was conducted with reference to the company's financial position as on March 31, 2025.
  • · The RBI found that the company failed to classify certain accounts as non-performing assets upon restructuring.
  • · The action is based on deficiencies in regulatory compliance and is not intended to pronounce on the validity of any transaction or agreement with customers.
  • · The penalty is without prejudice to any other action that may be initiated by RBI against the company.
Unknown Default negative materiality 4/10

17-07-2026

The Reserve Bank of India (RBI) imposed a monetary penalty of ₹2.70 lakh on Dhani Loans and Services Limited for non-compliance with asset classification directions. The company failed to classify certain loan accounts as non-performing assets (NPAs), as found during a statutory inspection as of March 31, 2025.

  • · The penalty was imposed under section 58G(1)(b) read with section 58B(5)(aa) of the Reserve Bank of India Act, 1934.
  • · The statutory inspection was conducted with reference to the company's financial position as on March 31, 2025.
  • · The RBI order was dated July 15, 2026, and the press release was issued on July 17, 2026.
  • · The penalty is without prejudice to any other action that may be initiated by RBI against the company.
Asian Tea & Exports Ltd. Fraud Investigation neutral materiality 3/10

17-07-2026

Asian Tea & Exports Ltd. received a closure report from the Deputy Commissioner of State Tax, Bureau of Investigation (South Bengal), regarding an inspection initiated under the West Bengal GST Act on November 21, 2025. The investigation found that the company initially failed to provide details of exempt supply (pulses) for FY 2022-23 through FY 2025-26, but after personal hearings and document submissions, the issue was reconciled with no tax liability. The company states there is no material financial or operational impact from this closure.

  • · Inspection initiated on 21-11-2025 at the company's registered office.
  • · Personal hearings held on 13-01-2026, 05-02-2026, 07-02-2026, and 26-02-2026.
  • · The company supplied tea at 5% GST (taxable) and pulses (exempt).
  • · All documents (bills of supply, weighing slips, purchase docs) were checked and reconciled with annual financial statements.
  • · Closure report received on 17-07-2026 via DIN No WBGST/1050/300626/0052Nq dated 30-06-2026.
Ugro Capital Limited Merger/Acquisition neutral materiality 6/10

17-07-2026

UGRO Capital Limited and Profectus Capital Private Limited have filed a Company Application with the National Company Law Tribunal (NCLT), Mumbai Bench, on July 16, 2026, to seek sanction for their proposed Scheme of Amalgamation. The scheme, which was approved by the board on January 8, 2026, and received observation letters from stock exchanges on July 10, 2026, remains subject to approvals from shareholders, creditors, the NCLT, and other regulators. No financial terms or performance metrics are disclosed in this procedural update.

  • · Company Application filed with NCLT Mumbai Bench on July 16, 2026.
  • · Scheme was earlier approved by the Board on January 8, 2026.
  • · Observation letters from stock exchanges were received on July 10, 2026.
  • · Scheme is under Sections 230 to 232 read with Section 52 of the Companies Act, 2013.
Unitech International Ltd Insolvency negative materiality 8/10

17-07-2026

Unitech International Ltd disclosed that the 11th meeting of its Committee of Creditors (CoC) held on June 18, 2026, approved a resolution to file an application seeking a 60-day extension of the Corporate Insolvency Resolution Process (CIRP) period. The company remains under CIRP, with the Resolution Professional noting that his AFA (Authorisation for Assignment) validity expired on June 30, 2026, which may raise compliance concerns.

  • · The 11th CoC meeting was conducted via video conferencing on June 18, 2026.
  • · The resolution to seek a 60-day CIRP extension was approved by the Committee of Creditors.
  • · The Resolution Professional's IBBI registration number is IBBI/IPA-002/IP-N00828/2019-2020/12629.
  • · The Resolution Professional's AFA (Authorisation for Assignment) validity expired on June 30, 2026, which is prior to the filing date of July 10, 2026.
Unknown SEBI Enforcement negative materiality 3/10

17-07-2026

SEBI issued a corrigendum to an adjudication order against Sonia Chadha in the matter of illiquid stock options trading at BSE. The original order and this corrigendum relate to enforcement action for alleged irregularities in illiquid stock options. No financial penalty or specific monetary amount is mentioned in this filing.

  • · The filing is a corrigendum to a prior adjudication order, indicating a correction or clarification to the original enforcement action.
  • · The matter involves alleged irregularities in illiquid stock options trading at BSE.
  • · No penalty amount or specific financial figure is disclosed in this filing.
Aditya Birla Capital Limited Merger/Acquisition neutral materiality 6/10

17-07-2026

Aditya Birla Capital Limited (ABCL) has invested ₹4,84,49,98,470 (₹484.49 Cr) on a rights basis in its subsidiary, Aditya Birla Sun Life Insurance Company Limited (ABSLI), to meet ABSLI's growth and funding requirements and improve its solvency margin. The investment was made in cash and was completed on July 17, 2026, with ABCL's shareholding in ABSLI remaining unchanged at 51%.

  • · The investment was made on a rights basis, meaning ABCL subscribed to its proportionate share of a rights issue by ABSLI.
  • · The transaction is classified as a related party transaction (ABSLI is a subsidiary of ABCL) but is stated to be at arm's length.
  • · No governmental or regulatory approvals were required for the acquisition.
  • · The investment is intended to improve ABSLI's solvency margin, a key regulatory capital requirement for insurance companies.
Oxford Industries ltd. Corporate Governance mixed materiality 9/10

17-07-2026

Oxford Industries Ltd. held a board meeting on July 17, 2026, approving a comprehensive corporate restructuring. Mr. Saroj Kumar Choudhary has completed an open offer and become the promoter with a 46.46% stake (27,61,576 shares), while the former promoter Mr. Mazher N Laila and his PACs have ceased to be promoters. The board also accepted the resignation of statutory auditor PAMS & Associates, proposed the appointment of Lipika & Associates as auditor for five years, appointed Mr. Choudhary as CFO, and proposed shifting the registered office from Maharashtra to Orissa, along with amendments to the MOA/AOA to include healthcare and pharmaceutical business objects. Additionally, a 99% reduction of share capital was proposed to address accumulated losses.

  • · The board meeting commenced at 4:00 PM and concluded at 5:40 PM on July 17, 2026.
  • · The resignation of PAMS & Associates was effective from June 19, 2026, due to geographical constraints after closure of their Mumbai branch in 2024.
  • · Lipika & Associates, proposed auditor, is headquartered in Noida with a branch in Mumbai, holds a Peer Review Certificate valid till January 31, 2029.
  • · The proposed new objects include hospitals, Medicare, nursing homes, pharmaceuticals, cosmetics, surgical equipment, and healthcare IT applications.
  • · The reduction of capital is specifically to offset accumulated business losses, and a registered valuer has been appointed for the valuation report.
Alkem Laboratories Limited Merger/Acquisition neutral materiality 7/10

17-07-2026

Alkem Laboratories announced the completion of its acquisition of a 51-55% stake in Occlutech Holding AG, a Swiss company, through its wholly owned subsidiary Alkem Medtech Private Limited. The acquisition makes Occlutech a step-down subsidiary of Alkem. No financial terms were disclosed.

  • · The acquisition was completed pursuant to a Share Purchase Agreement.
  • · Occlutech is a Swiss company.
  • · Previous intimations were made on 13th February 2026, 6th March 2026, and 29th June 2026.
India Glycols Limited Insolvency neutral materiality 8/10

17-07-2026

India Glycols Limited announced that the Hon'ble NCLT, Allahabad Bench at Prayagraj, has sanctioned the Scheme of Arrangement for the demerger of its Bio Pharma Undertaking into Ennature Bio Pharma Limited and its Spirits and Biofuel Undertaking into IGL Spirits Limited. The order was pronounced on July 17, 2026, and a copy will be submitted once uploaded on the NCLT website.

  • · The Scheme involves demerger of the Bio Pharma Undertaking into Ennature Bio Pharma Limited (Resulting Company 1) and the Spirits and Biofuel Undertaking into IGL Spirits Limited (Resulting Company 2).
  • · The NCLT order was pronounced on July 17, 2026, following a prior intimation dated July 3, 2026.
  • · The Scheme is under Sections 230 to 232 of the Companies Act, 2013.
Oxford Industries ltd. Market Notice mixed materiality 8/10

17-07-2026

Oxford Industries Ltd. held a Board Meeting on July 17, 2026, approving a comprehensive restructuring. Mr. Saroj Kumar Choudhary, who completed an open offer and now holds 46.46% (27,61,576 shares) of the paid-up capital, has become the promoter and Managing Director, while the former promoter Mr. Mazher N Laila and his PACs have been reclassified as public shareholders. The Board also accepted the resignation of statutory auditor PAMS & Associates (effective June 19, 2026, due to geographical constraints), proposed the appointment of Lipika & Associates as auditor for five years, appointed Mr. Choudhary as CFO, and proposed shifting the registered office from Maharashtra to Orissa, amending the MOA/AOA to add healthcare/pharmaceutical objects, and reducing share capital by 99% to offset accumulated losses — all subject to shareholder approval.

  • · The Board meeting commenced at 4:00 PM and concluded at 5:40 PM on July 17, 2026.
  • · The resignation of PAMS & Associates was effective from June 19, 2026, due to closure of their Mumbai branch in 2024 and geographical challenges.
  • · Lipika & Associates (FRN: 145364W) is proposed as auditor for FY 2026-27 to 2030-31, subject to AGM approval.
  • · The company proposes to shift its registered office from Maharashtra to Orissa, subject to shareholder approval.
  • · New objects include operating hospitals, nursing homes, diagnostic centres, and dealing in pharmaceuticals, cosmetics, and medical equipment.
  • · A registered valuer has been appointed for the capital reduction process.
Unitech International Ltd Insolvency negative materiality 7/10

17-07-2026

Unitech International Ltd, currently under the Corporate Insolvency Resolution Process (CIRP), has disclosed that the 12th meeting of the Committee of Creditors (CoC) was held on July 8, 2026, via video conferencing. The disclosure was made under Regulation 30 of SEBI (LODR) Regulations, 2015, and was filed with BSE Limited on July 17, 2026. No financial results or resolution outcomes were provided in the filing.

  • · The 12th CoC meeting was scheduled on July 8, 2026, at 4:00 PM IST through video conferencing.
  • · The Resolution Professional is Mr. Nitin Narang (IBBI Registration No. IBBI/IPA-002/IP-N00828/2019-2020/12629, AFA valid till June 30, 2026).
  • · The filing was made under Regulation 30 read with sub-clause 16(g) of Clause A of Part-A Schedule III of SEBI (LODR) Regulations, 2015.
Bloom Dekor Ltd. Insolvency negative materiality 9/10

17-07-2026

Bloom Dekor Ltd. has informed BSE that its Board has fixed July 31, 2026 as the Record Date for the reduction and cancellation of its existing share capital, pursuant to a resolution plan approved by the NCLT Ahmedabad Bench on June 18, 2026. The capital reduction will be implemented in accordance with the NCLT-approved plan, subject to necessary approvals from stock exchanges, depositories, and other regulators.

  • · Record Date: Friday, July 31, 2026
  • · NCLT order date: June 18, 2026
  • · Purpose: Determination of shareholders whose equity shares shall be subject to reduction/extinguishment
  • · Capital reduction subject to approvals from Stock Exchanges, Depositories, and other regulatory authorities
  • · Company Secretary: Krumil Patel, Membership No. A77863
Oxford Industries ltd. Open Offer mixed materiality 8/10

17-07-2026

Oxford Industries Ltd. announced a change in management following the completion of an open offer by Mr. Saroj Kumar Choudhary, who now holds 27,61,576 shares (46.46% of paid-up capital) and becomes the promoter, while the former promoter Mr. Mazher N Laila and his PACs cease to be promoters. The Board also approved the resignation of statutory auditor M/s. PAMS & Associates (effective June 19, 2026) due to geographical constraints, and proposed the appointment of M/s. Lipika & Associates as auditor for a 5-year term (FY 2026-27 to 2030-31), subject to shareholder approval. Additionally, the Board proposed a 99% reduction of share capital to offset accumulated losses, shifting of the registered office from Maharashtra to Orissa, and expansion of the main object clause to include healthcare and pharmaceutical businesses, all subject to shareholder approval.

  • · The Board meeting was held on July 17, 2026, from 4:00 PM to 5:40 PM at the registered office in Mumbai.
  • · Mr. Saroj Kumar Choudhary was also appointed as Chief Financial Officer (CFO) effective July 17, 2026.
  • · The proposed reduction of capital is to the extent of 99% of the issued and paid-up capital, subject to shareholder approval.
  • · The company plans to shift its registered office from Maharashtra to Orissa, subject to shareholder approval.
  • · The Board approved the adoption of new Memorandum of Association and Articles of Association, subject to shareholder approval.
  • · The new object clauses include businesses in hospitals, Medicare, nursing homes, pharmaceuticals, cosmetics, and healthcare IT.
  • · The resigning auditor, PAMS & Associates, confirmed no unresolved issues or qualifications requiring attention of members or creditors.
DCM Shriram Limited Merger/Acquisition positive materiality 7/10

17-07-2026

DCM Shriram Limited has entered into a definitive agreement with Serentica Renewables India 38 Private Limited to acquire a 26% equity stake in the SPV for ₹105 Crore, securing 58 MW of renewable power for its Bharuch plant. The investment will increase the company's total renewable energy capacity to 176 MW (peak) across its Bharuch and Kota sites. The project is expected to be commissioned by June 2027 and will help avoid approximately 0.4 million tonnes of CO₂ emissions annually.

  • · The project is a hybrid renewable energy project comprising 190 MW solar (from Rajasthan) and wind (from Karnataka) to supply 58 MW, with 36 MW round-the-clock.
  • · The target entity was incorporated on 1st January 2026; no financial history available.
  • · The investment is structured as cash consideration, and the acquisition is not a related party transaction.
  • · The agreement is expected to improve cost efficiency and reduce exposure to conventional energy price fluctuations.
  • · The definitive agreement was signed on 17th July 2026, and the project is expected to be commissioned by 30th June 2027.
Authum Investment & Infrastructure Limited Merger/Acquisition neutral materiality 6/10

17-07-2026

Authum Investment & Infrastructure Limited has received NCLT approval for its Resolution Plan to acquire Creatoz Builders Private Limited (CBPL), a real estate company undergoing Corporate Insolvency Resolution Process under the IBC. The acquisition allows Authum to invest in the real estate sector and monetize the underlying assets. No financial terms or performance metrics were disclosed in the filing.

  • · The NCLT order was uploaded on the IBBI website on July 16, 2026.
  • · The acquisition was originally announced on October 10, 2024.
  • · CBPL is a private limited company incorporated under the Companies Act, 1956, engaged in the real estate business.
Lippi Systems Ltd. Open Offer neutral materiality 6/10

17-07-2026

Vinesh Shivji Dholu and other acquirers have launched a mandatory open offer to acquire up to 33,82,231 equity shares (25.05% of expanded share capital) of Lippi Systems Ltd. from public shareholders at ₹56.84 per share, for a total consideration of approximately ₹19.22 Cr. The Independent Directors Committee (IDC) has recommended the offer price as fair and reasonable. The tendering period runs from July 20 to July 31, 2026.

  • · The open offer is mandatory under Regulation 3(1) and 4 of SEBI (SAST) Regulations.
  • · The offer is not conditional on any minimum level of acceptance.
  • · The IDC recommendation was approved on July 14, 2026 and published on July 15, 2026.
  • · The Letter of Offer was dispatched on July 10, 2026 via email and speed post.
  • · The offer represents 100% of the public shareholding (33,82,231 shares).
  • · Post-offer, the acquirers will hold 99.63% of the total shares (1,34,50,200 shares out of 1,35,00,000 expanded shares).
  • · The manager to the offer is Vivro Financial Services Private Limited.
  • · The filing also includes a corrigendum updating certain clauses of the DPS/LOF.
Lippi Systems Ltd. Open Offer neutral materiality 9/10

17-07-2026

Lippi Systems Ltd. has issued a pre-offer advertisement for a mandatory open offer by the Dholu family (Acquirers) to acquire up to 33,82,231 equity shares (25.05% of the expanded share capital) from public shareholders at ₹56.84 per share. The open offer follows a Share Purchase Agreement (SPA) and Share Subscription Agreement (SSA) under which the Acquirers will obtain 35,67,969 shares and 65,00,000 shares respectively, ultimately holding 99.63% of the company. The Independent Directors Committee has recommended the offer price as fair and reasonable. The tendering period runs from July 20 to July 31, 2026.

  • · The pre-offer advertisement cum corrigendum is published in Financial Express (English, all editions), Jansatta (Hindi, all editions), Financial Express (Gujarati, Ahmedabad edition), and Navshakti (Marathi, Mumbai edition).
  • · The Detailed Public Statement (DPS) was published on May 25, 2026; the Letter of Offer (LOF) was dispatched on July 10, 2026 via email and speed post.
  • · The IDC recommendation was approved on July 14, 2026 and published on July 15, 2026, deeming the offer price fair and reasonable.
  • · The offer is not conditional upon any minimum level of acceptance (Regulation 19(1) exemption).
  • · There are pending no regulatory actions against the target company or its promoters/directors under SEBI Act or regulations.
  • · The identified date for public shareholders is July 6, 2026.
Race Eco Chain Limited Merger/Acquisition neutral materiality 5/10

17-07-2026

Race Eco Chain Limited has invested INR 1,17,30,000 in Ganesha Recycling Chain Private Limited, its subsidiary, via a rights issue, receiving 1,17,300 equity shares. The investment maintains Race Eco Chain's existing 51% ownership stake in the subsidiary. The transaction is classified as a related party transaction but was conducted at arm's length, with no promoter or group company interest in the target.

  • · Ganesha Recycling Chain Private Limited was incorporated on September 10, 2024.
  • · The subsidiary is engaged in the recycling industry and operates in the Indian market.
  • · No turnover data is available for the acquired entity (last 3 years).
  • · No governmental or regulatory approvals were required for the acquisition.
New Delhi Television Limited Merger/Acquisition neutral materiality 5/10

17-07-2026

New Delhi Television Limited (NDTV) provided an update on its proposed acquisition of the 'GoodTimes' channel business undertaking from Lifestyle & Media Broadcasting Limited. The transaction is still under discussion and is now expected to close within approximately three months, subject to regulatory approvals and customary conditions. This update indicates a delay from the original timeline, though no specific financial terms or revised completion date were disclosed.

  • · The acquisition was initially disclosed on June 18, 2026.
  • · Completion is now expected within approximately 3 months from July 17, 2026.
  • · The transaction remains subject to statutory and regulatory approvals and customary conditions precedent.
Federated Hermes Project & Trade Finance Tender Fund SC TO-I/A negative materiality 3/10

17-07-2026

Federated Hermes Project & Trade Finance Tender Fund filed a final amendment to its tender offer, reporting that $0 of the authorized $51.9M repurchase was completed. No shares were tendered or accepted at the June 22, 2026 NAV of $10.21 per share for either Institutional or Service classes. The offer, which expired with zero participation, resulted in no capital being returned to shareholders.

  • · The tender offer was first published on April 16, 2026.
  • · The NAV per share for both Institutional and Service Shares was $10.21 as of June 22, 2026.
  • · This filing is a final amendment under Rule 13e-4(c)(4) to report the results of the offer.
  • · The total transaction valuation for fee calculation purposes was $51,913,127.88, but the actual transaction value was $0.
NIIT Learning Systems Limited Merger/Acquisition neutral materiality 4/10

17-07-2026

NIIT Learning Systems Limited announced the merger of its wholly owned step-down subsidiary StackRoute Learning Inc. (SLI) into its direct wholly owned subsidiary NIIT (USA) Inc. The merger, approved by the boards of both entities on July 17, 2026, is aimed at leveraging combined capabilities for enterprise clients, operational simplification, and cost reduction. The transaction involves no cash or share consideration and is not expected to have a material impact on the consolidated financials of the company.

  • · The merger is subject to applicable regulatory approvals and customary legal/procedural formalities.
  • · Post-merger, SLI will cease to exist and all of NIIT USA's investment in SLI's share capital will be cancelled.
  • · The merger will not change the shareholding pattern of NIIT USA or any other subsidiary of the company.
  • · SLI has created strong capability in delivering technology programs including AI, Cyber, Cloud, and Data.
VEEFIN SOLUTIONS LIMITED Insolvency neutral materiality 6/10

17-07-2026

VeeFin Solutions Limited held a meeting of unsecured creditors on July 17, 2026, as directed by the NCLT Mumbai Bench (order dated May 13, 2026), to consider and approve a Scheme of Amalgamation (merger by absorption) of GlobeTF Solutions Limited and Estorifi Solutions Limited into VeeFin Solutions. Of the 113 unsecured creditors as of the record date, only 15 attended the meeting, and no queries or comments were raised by any creditor on the scheme. The voting results are pending receipt of the scrutinizer's report.

  • · The meeting was held via Video Conference / Other Audio Visual Means and lasted from 10:00 AM to 10:23 AM IST.
  • · The e-voting facility was kept open for 15 minutes after the meeting for creditors who had not yet voted.
  • · The resolution required a requisite majority as prescribed under Section 230(6) of the Companies Act, 2013.
  • · No creditor requested to speak or raised any queries, comments, or clarifications on the scheme.
Jana Small Finance Bank Limited Default negative materiality 8/10

17-07-2026

Jana Small Finance Bank disclosed a divergence in asset classification and provisioning for NPAs as per the RBI's Risk Assessment Report for FY 2024-25. The RBI assessed gross NPAs at ₹919 crore versus the bank's reported ₹750 crore, a divergence of ₹169 crore, and net NPAs at ₹423 crore versus ₹254 crore. The bank has already provided for the additional provisioning of ₹42 crore in FY 2025-26, resulting in no impact on the P&L for FY 2026-27.

  • · The divergence in Gross NPAs was ₹169 crore, representing 22.5% of the bank's reported Gross NPAs of ₹750 crore.
  • · The divergence in Net NPAs was also ₹169 crore, representing 66.5% of the bank's reported Net NPAs of ₹254 crore.
  • · The additional provisioning required was ₹42 crore, which reduced the notional PAT from ₹501 crore to ₹459 crore.
  • · The bank has already provided for the divergence in FY 2025-26, so there is no impact on the P&L for FY 2026-27.
Samvardhana Motherson International Limited Merger/Acquisition neutral materiality 8/10

17-07-2026

Samvardhana Motherson International Limited, through its indirect wholly owned subsidiary Motherson Global Investments B.V., is acquiring an 81% stake in Yutaka Giken Co., Ltd. (YGCL) and an 11% stake in Shinnichi Kogyo Co., Ltd. The company received the Voluntary Sale Permission Decision from the competent court on July 17, 2026, and expects to complete the acquisition in Q2 FY2026-27. No financial terms or performance metrics were disclosed in this update.

  • · The acquisition was initially disclosed on August 29, 2025.
  • · YGCL was listed on the Tokyo Stock Exchange.
  • · The Voluntary Sale Permission Decision from the competent court was received on July 17, 2026.
  • · Payment for fractional share transfer will be completed per definitive agreements.
  • · The acquisition is expected to close in Q2 FY2026-27.
Anupam Rasayan India Limited Merger/Acquisition neutral materiality 5/10

17-07-2026

Anupam Rasayan India Ltd. has completed the acquisition of 100% equity shares of Mates Visa Consultancy Private Limited for a cash consideration of INR 10,000, making it a wholly-owned subsidiary. The acquisition is part of a group restructuring exercise to rationalize investments, including the proposed acquisition of equity shares of Bliss GVS Pharma Limited. The target company, with an audited turnover of INR 0.31 crore (approx. INR 31.40 lakh) for FY 2025-26, operates in the immigration and visa consultancy sector, which is outside Anupam Rasayan's main line of business.

  • · The acquisition was completed on July 17, 2026, the same date as the filing.
  • · Mates Visa Consultancy was incorporated on May 25, 2022, and is based in Karnal, Haryana.
  • · The target company's board and shareholders have passed resolutions to amend its objects and name to align with Anupam Rasayan's permitted activities.
  • · The acquisition does not fall within the definition of a related party transaction, and the promoter/promoter group/group companies have no interest in the target.
  • · No governmental or regulatory approvals were required for the acquisition.
Fuse Science, Inc. 8-K negative materiality 10/10

17-07-2026

Fuse Science, Inc. has had a receiver appointed by the Clark County District Court in Nevada after failing to satisfy a $643,471 judgment obtained by creditors Mina Mar Group, Mina 12, and Worldways Inc. The company reported $0 in assets and $0 in cash as of December 31, 2026, is insolvent, and has relocated its headquarters and assets abroad. The receiver, Peter D. Downey, has full authority to take control of all assets, investigate insider transactions, and wind down the business, while the company and its officers are enjoined from transferring assets or issuing shares.

  • · The receiver is authorized to investigate all transfers of assets and shares, including insider transactions, and to cancel improperly issued shares.
  • · The company is permanently enjoined from transferring, encumbering, or disposing of any assets, and from issuing any shares of capital stock.
  • · All financial institutions and third parties holding assets of Fuse Science must turn them over to the receiver upon demand.
  • · The receiver may retain professionals (attorneys, accountants, consultants) without prior court approval for expenditures up to $10,000 per matter.
  • · The receiver is not required to post a bond at this time, and is not personally liable for acts taken in good faith except for willful misconduct or gross negligence.
Dare Bioscience, Inc. 8-K negative materiality 9/10

17-07-2026

Dare Bioscience, Inc. received a delisting notice from Nasdaq on July 13, 2026, because its stockholders' equity fell below $2.5 million as of March 31, 2026, and it failed to meet alternative listing requirements of $35 million in market value of listed securities or $500,000 in net income from continuing operations. The company intends to request a hearing before a Nasdaq Hearing Panel to stay the delisting, but there is no assurance of success. This development poses a significant risk to the company's continued listing on the Nasdaq Capital Market.

  • · The delisting notice was issued by the Listing Qualifications Staff of Nasdaq on July 13, 2026.
  • · The company's common stock trades under the symbol DARE on the Nasdaq Capital Market.
  • · The company intends to timely request a hearing before a Nasdaq Hearing Panel, which will stay the suspension and delisting pending the Panel's decision and any extension period granted.
  • · There is no assurance that the Panel will grant an extension or that the company will regain compliance.
Calisa Acquisition Corp 8-K neutral materiality 3/10

17-07-2026

Calisa Acquisition Corp (ALISR) filed an 8-K on July 16, 2026, disclosing that its merger partner, GoodVision AI Inc., announced the establishment of its first next-generation AI Factory in Japan. The disclosure is furnished under Regulation FD and includes forward-looking statements regarding the proposed business combination. No financial figures or period-over-period comparisons were provided in this filing.

  • · The press release was issued by GoodVision AI Inc., not by Calisa Acquisition Corp.
  • · The AI Factory is described as 'next-generation' but no further details on capacity, investment, or timeline were provided.
  • · The filing includes extensive cautionary language about forward-looking statements and risks related to the merger.
  • · The BCA (Business Combination Agreement) was previously entered into between GoodVision and Calisa.
  • · The Company's securities trade on Nasdaq under symbols ALISU (Units), ALIS (Ordinary Shares), and ALISR (Rights).
ACTUATE THERAPEUTICS, INC. 8-K negative materiality 9/10

17-07-2026

Actuate Therapeutics received a Nasdaq Staff notice on July 15, 2026, that its Market Value of Listed Securities (MVLS) has been below the $50 million minimum required for continued listing on The Nasdaq Global Market since June 1, 2026. The company has 180 calendar days, until January 11, 2027, to regain compliance by closing at $50 million or more for ten consecutive business days. While the company intends to take all reasonable measures to regain compliance, there is no assurance it will succeed, and failure could lead to delisting or a transfer to the Nasdaq Capital Market.

  • · The non-compliance period for MVLS was measured from June 1, 2026 to July 14, 2026.
  • · The Notice has no immediate effect on the listing; the stock continues to trade under the symbol 'ACTU'.
  • · If compliance is not regained by the Compliance Date, Nasdaq will issue a delisting notice, which the company may appeal.
  • · The company may alternatively apply for a transfer to The Nasdaq Capital Market.
Inflection Point Acquisition Corp. V 8-K neutral materiality 6/10

17-07-2026

Inflection Point Acquisition Corp. V (SPAC) and GOWell Technology Limited amended their business combination agreement on July 13, 2026, modifying the earnout share issuance thresholds for 2026 EBITDA performance and capping SPAC transaction expenses at $9 million. The amendment also adds a new schedule for advisory fees, with cash advisory fees to Cohen & Company Capital Markets capped at $2 million. The deal structure remains otherwise unchanged.

  • · The amendment is the second amendment to the original Business Combination Agreement dated October 13, 2025 (first amendment on December 22, 2025).
  • · The earnout share issuance is a one-time event per tier, not cumulative.
  • · Deferred underwriting commissions and non-cash advisory fees of Cohen & Company Capital Markets are excluded from the $9M SPAC expense cap.
  • · The amendment adds a new Schedule 11.3 to the agreement detailing advisory services.

Get daily alerts with 10 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: Global High-Priority Regulatory Events

🇺🇸 More from United States

View all →